Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,716.00
Bid: 1,715.50
Ask: 1,716.50
Change: 11.00 (0.65%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,717.00
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Asian data lifts stocks early on

Mon, 02nd Jul 2012 08:30

- Chinese, Japanese data comes in better than expected- RBS falls on Libor issues- Barclays Chairman resignsLondon's blue chips edged higher on Monday morning after manufacturing data in China and Japan boosted sentiment.China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last month, according to the National Bureau of Statistics and China Federation of Logistics and Purchasing, beating forecasts of around 49.9.Meanwhile, Japan's Tankan manufacturers' sentiment survey improved from minus four to minus one in the second quarter, compared to expectations of an unchanged ready.Investors will be looking ahead to policy decisions in both the UK and Europe around Thursday lunchtime. The Monetary Policy Committee (MPC) will be revealing its policy decision with the majority of economists expecting the Bank of England (BoE) to ramp up its asset purchase programme while keeping rates where they are.The European Central Bank (ECB) is anticipated to slash its main refinancing rate to a record-low 0.75%, compared with the current 1% level. 48 of the 71 economists surveyed by Reuters expect a reduction. FTSE 100: Banks continue to be dampened by Libor scandalRoyal Bank of Scotland (RBS) was a heavy faller after Oriel Securities downgraded its rating on the stock to 'hold'. It was revealed at the weekend that the bank had sacked four of its traders last year over the alleged manipulation of interbank lending rates (London Interbank Offered Rate, or LIBOR). Some market reports said that some 10 traders were dismissed, citing unidentified sources.The news comes after last week's revelation that banking peer Barclays had been fined £290m after it was found attempting to control submissions for LIBOR to benefit its interest rate derivatives. The issue prompted the lender's Chairman Marcus Agius to resign this morning. He said he is "truly sorry" that the bank's customers, clients, employees and shareholders have been let down. Barclay swung between gains and losses early on following last week's sell-off.Insurance group Aviva rose after announcing that Chairman Lord Sharman retired as Chairman on June 30th. John McFarlane has taken over.Pharmaceuticals giant AstraZeneca edged higher after saying that Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals will strengthen the leadership position of its diabetes alliance with Bristol-Myers in a "growing area of high unmet medical need". Astra will make a payment of $3.4bn in cash to Amylin once it becomes a wholly-owned subsidiary of Bristol-Myers.Sector peer GlaxoSmithKline also advanced after revealing positive results from four pivotal phase III studies for its once-daily COPD treatment. The company said that the results of the studies support its intention to commence global regulatory submissions for the treatment from the end of 2012.Serco, the international services company, rose after it signed an agreement to dispose of most of its operations in Germany in a transaction with the local management team.Media giant WPP was in demand after announcing another acquisition; it has agreed to acquire the South Korean media planning and buying agency, Alchemedia, which will be merged into its GroupM Korea subsidiary.FTSE 250: Catlin falls after broker downgradeInsurance group Catlin fell after Jefferies downgraded the stock to 'hold' as part of its review into the European insurance industry: "With Catlin now close to our price target, we downgrade to 'hold' also noting higher end US windstorm exposure and a broadly untouched reinsurance deductible."Oil and gas group SOCO International jumped after entering into a 'conditional' agreement with Lizeroux Oil & Gas to acquire the 20% minority interest in SOCO Vietnam that the group does not already own. FTSE 100 - RisersStandard Chartered (STAN) 1,418.50p +2.46%Barclays (BARC) 166.00p +1.93%WPP (WPP) 786.00p +1.68%Aviva (AV.) 276.80p +1.54%Burberry Group (BRBY) 1,345.00p +1.51%Prudential (PRU) 748.50p +1.42%Lloyds Banking Group (LLOY) 31.50p +1.27%BP (BP.) 427.20p +1.24%G4S (GFS) 282.40p +1.18%Tullow Oil (TLW) 1,487.00p +1.16%FTSE 100 - FallersXstrata (XTA) 780.20p -2.30%Shire Plc (SHP) 1,796.00p -1.97%Glencore International (GLEN) 290.45p -1.73%Royal Bank of Scotland Group (RBS) 211.70p -1.67%Tesco (TSCO) 306.45p -1.16%Vodafone Group (VOD) 177.45p -1.00%Evraz (EVR) 258.30p -0.92%British Sky Broadcasting Group (BSY) 690.50p -0.86%Smith & Nephew (SN.) 632.50p -0.78%International Consolidated Airlines Group SA (CDI) (IAG) 158.30p -0.75%FTSE 250 - RisersSoco International (SIA) 302.80p +4.63%Imagination Technologies Group (IMG) 487.60p +4.50%Aquarius Platinum Ltd. (AQP) 47.40p +3.81%Essar Energy (ESSR) 125.90p +3.20%Invensys (ISYS) 229.00p +2.83%BH Global Ltd. USD Shares (BHGU) 11.45 +2.69%Fenner (FENR) 370.70p +2.60%Shanks Group (SKS) 78.30p +2.55%FirstGroup (FGP) 229.40p +2.27%TR Property Inv Trust (TRY) 151.30p +2.23%FTSE 250 - FallersSpirit Pub Company (SPRT) 49.50p -2.46%Catlin Group Ltd. (CGL) 417.80p -1.81%Victrex (VCT) 1,249.00p -1.73%Cranswick (CWK) 801.00p -1.72%Halfords Group (HFD) 225.50p -1.61%New World Resources A Shares (NWR) 318.60p -1.51%Barr (A.G.) (BAG) 393.60p -1.40%Ruspetro (RPO) 133.40p -1.26%easyJet (EZJ) 525.50p -1.13%Renishaw (RSW) 1,386.00p -1.00%BC
More News
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.